FHL CAPITAL CASE STUDY: SALE OF PHARMACEUTICAL PRODUCT LINE THE NEED Cebert Pharmaceuticals was founded to acquire, license, develop, market and distribute prescription and OTC pharmaceutical products. Substantially all of Cebert’s revenues came from selling Methadone HCl products for opioid addiction treatment. The company also had two promising new products in late pre-clinical development. Cash flows from the Methadone business were being aggressively reinvested into new product development. Without warning, regulatory changes caused the Methadone business to change dramatically and Cebert’s management projected that revenues would drop by over 50%. The Methadone products would no longer be profitable for Cebert. The company had a short window of time until projected operating

Join for free to read